Revisiting previously published gene expression data for this group of breast cancer cell lines, which lack CD33+ MDSC induction, we identified FLT3L and TGFβ as differentially expressed candidates for CD11b+ MDSC subset induction from our panel of putative MDSC-inducing factors [16]. This evidence concerns the gene CD33 and breast carcinoma.